Reagents, Immunoassay, Immunology, Cell Typing
Definition : Immunology reagents used for classification (i.e., typing) of human cells involved in humoral and/or cellular immunologic responses, frequently by determining the antigens (e.g., proteins) that are expressed on the cell surface. Cell typing is used to differentiate leukocytes from other cells, identify and quantify subsets of lymphocytes and monocytes/macrophages, and classify malignant cells for proper identification of neoplasms.
Entry Terms : "Typing Reagents, Cell" , "Cell Typing Reagents" , "Reagents, Leukemia Cell Immunophenotype"
UMDC code : 19192
Aldagen is a clinical-stage biopharmaceutical company developing proprietary regenerative cell therapies. Our product candidates consist of a specific population of a patient's own stem cells, which are isolated using our proprietary technology and which we believe have the potential to promote the regeneration of multiple types of cells and tissues, including the growth of new blood vessels.
The Binding Site Inc
At Binding Site we constantly strive to improve the tools available to laboratory professionals around the world for diagnosing and monitoring disease. Our origins date back to a group of researchers within the Medical School of Birmingham University who first started looking at innovative ways of producing antibodies in the early 1970's. With a desire to continue this early work but lacking the required government funding they founded a private company to take the research forward and utilise any potential commercial benefits. That company has evolved into The Binding Site and for over 25 years we have specialised in producing highly sensitive and highly specific antibodies used for the detection of certain cancers and other serious disorders.
Veridex, LLC is an organization dedicated to providing physicians with high-value in vitro diagnostic oncology products. Veridex's products may significantly benefit patients by helping physicians make more informed decisions that enable better patient care.